SCHEMBL6304615

SCHEMBL6304615

CNC(=O)c1cc2nccc(Cl)c2s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN3B O60391 13/20 0.45
GRIN1 Q05586 13/20 0.45
GRIN2C Q14957 13/20 0.45
GRIN2D O15399 1/20 0.45
GRIN2A Q12879 1/20 0.45
GRIN2B Q13224 1/20 0.45
POLB P06746 1/20 0.43
PKM P14618 1/20 0.43
RAB9A P51151 2/20 0.43
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL306971 0.85 GRIN3B (0.43) GRIN3BGRIN1GRIN2CGRIN2DGRIN2A
SCHEMBL7668542 0.85 POLB (0.45) GRIN3BGRIN1GRIN2CGRIN2DGRIN2A
SCHEMBL6304459 0.85 GRIN3B (0.53) GRIN3BGRIN1GRIN2CGRIN2DGRIN2A
SCHEMBL10288661 0.83 USP7 (0.42) GRIN3BGRIN1GRIN2CGRIN2DGRIN2A
SCHEMBL29368150 0.82 KDR (0.46) GRIN3BGRIN1GRIN2CGRIN2DGRIN2A
SCHEMBL1460546 0.82 KDR (0.46) GRIN3BGRIN1GRIN2CGRIN2DGRIN2A
SCHEMBL29998454 0.81 DAO (0.46) GRIN3BGRIN1GRIN2CGRIN2DGRIN2A
SCHEMBL198179 0.81 GRIN3B (0.38) GRIN3BGRIN1GRIN2CGRIN2DGRIN2A
SCHEMBL199636 0.81 DAO (0.46) GRIN3BGRIN1GRIN2CGRIN2DGRIN2A
Hydrochloric Acid SCHEMBL29368472 0.81 KDR (0.45) GRIN3BGRIN1GRIN2CGRIN2DGRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6964961-B2 Thiophene derivatives useful as anticancer agents PFIZER INC (US) 2005-11-15 US disclosed
EP-1287001-B1 THIOPHENE DERIVATIVES USEFUL AS ANTICANCER AGENTS PFIZER PROD INC (US) 2004-09-29 EP disclosed
EP-1287001-A1 THIOPHENE DERIVATIVES USEFUL AS ANTICANCER AGENTS Pfizer Products Inc. (US) 2003-03-05 EP disclosed
US-20020042409-A1 Thiophene derivatives useful as anticancer agents PFIZER PRODUCTS INC. 2002-04-11 US disclosed
WO-2001094353-A1 THIOPHENE DERIVATIVES USEFUL AS ANTICANCER AGENTS PFIZER PRODUCTS INC. (US) 2001-12-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020042409-A1 Thiophene derivatives useful as anticancer agents TP53, RCC1, CCNA1 GRIN3B 4823/4885GRIN1 4126/4885GRIN2C 4769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.